Myriad Genetics, Inc.MYGNNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P14
Within normal range
vs 2Y Ago
-0.4x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -4.00% |
| 2024 | -2.25% |
| 2023 | 11.31% |
| 2022 | -4.30% |
| 2021 | 7.41% |
| 2020 | -1.30% |
| 2019 | -8.86% |
| 2018 | 19.16% |
| 2017 | -1.95% |
| 2016 | 32.66% |